FORMULATIONS INJECTABLE OU ADMINISTRABLE PAR VOIE ORALE DE DERIVES D'AZETIDINE

Injectable or oral composition comprises azetidine derivatives (A), polysorbate 80 (polyethylene glycol monooleate), Solutol HS15 (polyethylene glycol hydroxystearate) and optionally ethanol, propylene glycol or PEG-400 as co-solvent. Injectable or oral composition comprises azetidine derivatives (A...

Full description

Saved in:
Bibliographic Details
Main Authors GAUDEL GILBERT, PERACCHIA MARIA TERESA, COTE SOPHIE
Format Patent
LanguageFrench
Published 23.03.2007
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Injectable or oral composition comprises azetidine derivatives (A), polysorbate 80 (polyethylene glycol monooleate), Solutol HS15 (polyethylene glycol hydroxystearate) and optionally ethanol, propylene glycol or PEG-400 as co-solvent. Injectable or oral composition comprises azetidine derivatives (A) of formula (IA) or (IB), Polysorbate 80 (polyethylene glycol monooleate), Solutol HS15 (polyethylene glycol hydroxystearate) and optionally ethanol, propylene glycol or PEG-400 as co-solvent. Ar = (hetero)aromatic (optionally substituted by 1-4C alkyl, halo, NO, CN, 1-4C alkoxy or OH). [Image].
Bibliography:Application Number: FR20040013937